News from insmed incorporated A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 13, 2012, 08:00 ET

Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies...

Nov 13, 2012, 08:00 ET

Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Nov 12, 2012, 08:00 ET

Insmed To Present At Two Upcoming Investor Conferences

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Nov 07, 2012, 07:15 ET

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...

Nov 07, 2012, 07:00 ET

Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Oct 24, 2012, 08:00 ET

Insmed to Host 2012 Third Quarter Earnings Conference Call

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...

Sep 28, 2012, 08:23 ET

Insmed Announces Pricing of Approximately $26 Million Direct Public Offering

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...

Sep 11, 2012, 08:00 ET

Insmed Appoints Will Lewis as President and Chief Executive Officer

 Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...

Aug 30, 2012, 08:00 ET

Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...

Aug 14, 2012, 08:00 ET

Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...

Aug 07, 2012, 07:00 ET

Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...

Aug 06, 2012, 08:00 ET

Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Aug 02, 2012, 08:00 ET

Insmed Receives Second Composition Of Matter Patent For ARIKACE®

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Jul 30, 2012, 08:00 ET

Insmed Announces Planned Departure Of Chief Financial Officer

MONMOUTH JUNCTION, N.J., July 30, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on...

Jul 24, 2012, 08:00 ET

Insmed to Host 2012 Second Quarter Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the lung,...

Jul 10, 2012, 08:00 ET

Insmed To Present At JMP Securities 7th Annual Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Jul 02, 2012, 08:00 ET

Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...

Jun 27, 2012, 08:00 ET

Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the first patient has been dosed in the Company's...

May 30, 2012, 08:00 ET

Insmed Provides Corporate Update

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today provided a corporate update, including the Company's current...

May 23, 2012, 08:00 ET

Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge